Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor
- PMID: 16002459
- DOI: 10.1124/jpet.105.090134
Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor
Abstract
Xanomeline is a functionally selective M1/M4 muscarinic acetylcholine receptor agonist. We have previously identified a novel mode of interaction of this ligand with the muscarinic M1 receptor that involves persistent binding and activation of the receptor after extensive washout. In the present study, we tested the hypothesis that xanomeline also binds in a wash-resistant manner to muscarinic receptor subtypes where it exhibits low or no efficacy, such as the M5 receptor subtype. A secondary hypothesis is that persistent binding of xanomeline to the M5 receptor results in wash-resistant antagonism to the effects of full agonists. These hypotheses were tested in Chinese hamster ovary cells stably expressing the M5 receptor. In these cells, xanomeline is a weak partial agonist and is able to inhibit carbachol-induced phosphoinositide hydrolysis to the maximal response of xanomeline in a concentration-dependent manner. Pretreatment with xanomeline followed by extensive washing resulted in a significant wash-resistant reduction in receptor affinity with no significant change in maximal cell surface receptor density. This was associated with wash-resistant antagonism of carbachol-induced activation of phosphoinositide hydrolysis at the M5 receptor, reflected as decreased carbachol potency without a change in the maximal response. Similar experiments using the partial agonist pilocarpine demonstrated a reduction of pilocarpine potency as well as maximal response. Our results clearly indicate that wash-resistant binding of xanomeline to the muscarinic M5 receptor is accompanied by persistent antagonism of receptor function. They also suggest a relationship between the efficacy of xanomeline and the functional consequences of its wash-resistant binding at different muscarinic receptor subtypes.
Similar articles
-
Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.Mol Pharmacol. 2006 Aug;70(2):656-66. doi: 10.1124/mol.106.023762. Epub 2006 May 4. Mol Pharmacol. 2006. PMID: 16675658
-
Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex.J Pharmacol Exp Ther. 2007 Dec;323(3):868-76. doi: 10.1124/jpet.107.129940. Epub 2007 Sep 12. J Pharmacol Exp Ther. 2007. PMID: 17855477
-
Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor.J Pharmacol Exp Ther. 2002 Jun;301(3):1033-41. doi: 10.1124/jpet.301.3.1033. J Pharmacol Exp Ther. 2002. PMID: 12023535
-
Interventions to reduce harm from continued tobacco use.Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3. Cochrane Database Syst Rev. 2016. PMID: 27734465 Free PMC article. Review.
-
Platelet-rich therapies for musculoskeletal soft tissue injuries.Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD010071. doi: 10.1002/14651858.CD010071.pub3. Cochrane Database Syst Rev. 2014. PMID: 24782334 Free PMC article. Review.
Cited by
-
Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.Neurochem Res. 2009 Jun;34(6):1138-49. doi: 10.1007/s11064-008-9886-3. Epub 2008 Dec 12. Neurochem Res. 2009. PMID: 19082883 Free PMC article.
-
Allosteric Modulation of Muscarinic Receptors by Cholesterol, Neurosteroids and Neuroactive Steroids.Int J Mol Sci. 2022 Oct 28;23(21):13075. doi: 10.3390/ijms232113075. Int J Mol Sci. 2022. PMID: 36361865 Free PMC article. Review.
-
3-[3-(3-florophenyl-2-propyn-1-ylthio)-1, 2, 5-thiadiazol-4-yl]-1, 2, 5, 6-tetrahydro-1- methylpyridine oxalate, a novel xanomeline derivative, improves neural cells proliferation and survival in adult mice.Neural Regen Res. 2012 Jan 5;7(1):24-30. doi: 10.3969/j.issn.1673-5374.2012.01.004. Neural Regen Res. 2012. PMID: 25806054 Free PMC article.
-
Molecular targets for treating cognitive dysfunction in schizophrenia.Schizophr Bull. 2007 Sep;33(5):1100-19. doi: 10.1093/schbul/sbm074. Epub 2007 Jul 7. Schizophr Bull. 2007. PMID: 17617664 Free PMC article. Review.
-
Investigation of the presence and antinociceptive function of muscarinic acetylcholine receptors in the African naked mole-rat (Heterocephalus glaber).J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2016 Jan;202(1):7-15. doi: 10.1007/s00359-015-1048-x. Epub 2015 Oct 31. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2016. PMID: 26520141 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases